Navamedic ASA (OSL:NAVA)

Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of NOK 503.61 million. The enterprise value is 637.67 million.

Market Cap	503.61M
Enterprise Value	637.67M

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Navamedic ASA has 23.98 million shares outstanding.

Current Share Class	23.98M
Shares Outstanding	23.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.09%
Owned by Institutions (%)	31.30%
Float	21.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	50.00
PS Ratio	0.89
PB Ratio	1.51
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	20.82
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-27.09
EV / Sales	1.13
EV / EBITDA	13.39
EV / EBIT	39.23
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.55, with a Debt / Equity ratio of 0.62.

Current Ratio	1.55
Quick Ratio	0.83
Debt / Equity	0.62
Debt / EBITDA	4.37
Debt / FCF	n/a
Interest Coverage	0.58

Financial Efficiency

Return on equity (ROE) is -8.55% and return on invested capital (ROIC) is 3.47%.

Return on Equity (ROE)	-8.55%
Return on Assets (ROA)	1.68%
Return on Invested Capital (ROIC)	3.47%
Return on Capital Employed (ROCE)	2.87%
Weighted Average Cost of Capital (WACC)	6.78%
Revenue Per Employee	13.46M
Profits Per Employee	-560,429
Employee Count	42
Asset Turnover	0.94
Inventory Turnover	3.48

Taxes

In the past 12 months, Navamedic ASA has paid 7.88 million in taxes.

Income Tax	7.88M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.33% in the last 52 weeks. The beta is 0.17, so Navamedic ASA's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	-2.33%
50-Day Moving Average	22.71
200-Day Moving Average	22.38
Relative Strength Index (RSI)	36.73
Average Volume (20 Days)	9,590

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of NOK 565.36 million and -23.54 million in losses.

Revenue	565.36M
Gross Profit	220.32M
Operating Income	16.25M
Pretax Income	-15.66M
Net Income	-23.54M
EBITDA	47.61M
EBIT	16.25M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 74.16 million in cash and 208.22 million in debt, with a net cash position of -134.07 million or -5.59 per share.

Cash & Cash Equivalents	74.16M
Total Debt	208.22M
Net Cash	-134.07M
Net Cash Per Share	-5.59
Equity (Book Value)	334.08M
Book Value Per Share	n/a
Working Capital	96.77M

Cash Flow

Operating Cash Flow	24.19M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 38.97%, with operating and profit margins of 2.87% and -4.16%.

Gross Margin	38.97%
Operating Margin	2.87%
Pretax Margin	-2.77%
Profit Margin	-4.16%
EBITDA Margin	8.42%
EBIT Margin	2.87%
FCF Margin	n/a

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.67%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5